This Week In Cannabis: DEA Slams Legal Weed, Texas Votes Hemp Ban, Argentina Tightens Medical Rules And More Cannabis news of the week: Texas targets hemp, DEA blames legal states, Argentina revamps REPROCANN, and Tilray expands in Europe.
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Why Curaleaf Stock Dropped After Earnings Investors turn up their noses at Curaleaf, but that could be a mistake.
Germany's Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approved Germany's cannabis access surges with 2,500 pharmacies and 211 grow clubs, but bans on edibles and retail sales still limit the market's full potential.
DeSantis Signs New Petition Law That Could Block Marijuana Ballot Campaign—Lawsuit Challenges Constitutionality Florida's new ballot law targets cannabis legalization efforts and sparks a federal lawsuit. Major backers include Trulieve, Verano, Curaleaf.
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp' Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet.
